Chicago Partners Investment Group LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Chicago Partners Investment Group LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,544
-75.5%
14,0250.0%0.00%
Q2 2023$6,311
-13.2%
14,0250.0%0.00%
Q1 2023$7,273
-25.1%
14,0250.0%0.00%
-100.0%
Q4 2022$9,715
-39.3%
14,0250.0%0.00%0.0%
Q3 2022$16,0000.0%14,0250.0%0.00%0.0%
Q2 2022$16,000
+128.6%
14,0250.0%0.00%0.0%
Q1 2022$7,00014,0250.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 2,564,925$11,132,0008.99%
Essex Woodlands Management, Inc. 2,764,908$11,330,0005.70%
Third Security, LLC 17,815,708$77,320,0003.68%
MSD Partners, L.P. 2,750,000$11,935,0000.49%
SFMG, LLC 99,850$433,0000.15%
GM Advisory Group, LLC 12,500$54,0000.06%
Geduld E E 25,000$109,0000.05%
WESTPORT RESOURCES MANAGEMENT INC 30,500$132,0000.04%
Janney Montgomery Scott LLC 335,571$1,456,378,0000.04%
WFG Advisors, LP 48,040$208,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders